Glucocerebrosidase as a genetic modifier influencing susceptibility and phenotype of Parkinson’s disease

By Latsoudis Helen   Papapetropoulos Spyridon  

Future Neurology, Vol. 5, Iss. 2, 2010-03 ,pp. : 189-193

Future Medicine

Access to resources Recommend Favorite

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

By Williams David R.  

Brain, Vol. 128, Iss. 6, 2005-06 ,pp. : 1247-1258

Oxford University Press

Access to resources Recommend Favorite

Pathologically proven frontotemporal dementia presenting with severe amnesia

By Graham Andrew  

Brain, Vol. 128, Iss. 3, 2005-03 ,pp. : 597-605

Oxford University Press

Access to resources Recommend Favorite

Glucocerebrosidase mutations influence the natural history of Parkinsons disease in a community-based incident cohort

By Winder-Rhodes Sophie E.  

Brain, Vol. 136, Iss. 2, 2013-02 ,pp. : 392-399

Oxford University Press

Access to resources Recommend Favorite

Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data

By Khan Naheed L.   Jain Shushant   Lynch John M.   Pavese Nicola   Abou-Sleiman Patrick   Holton Janice L.   Healy Daniel G.   Gilks William P.   Sweeney Mary G.   Ganguly Milan   Gibbons Vaneesha   Gandhi Sonia   Vaughan Jenny   Eunson Louise H.   Katzenschlager Regina   Gayton Juliet   Lennox Graham   Revesz Tamas   Nicholl David   Bhatia Kailash P.   Quinn Niall   Brooks David   Lees Andrew J.   Davis Mary B.   Piccini Paola   Singleton Andrew B.   Wood Nicholas W.  

Brain, Vol. 128, Iss. 12, 2005-12 ,pp. : 2786-2796

Oxford University Press

Access to resources Recommend Favorite